New formats needed 
Clinical trial data released this year in a study of cisgender men, transgender men, transgender women, and nonbinary individuals who have sex with partners assigned male at birth showed that using lenacapavir results in a 96% 
‘In my view, it’s analogous to dispensing a new drug that you haven’t come across before. You understand the relevant information related to the drug from a safety and effectiveness point of view, you communicate with the patient regarding relevant counselling points, and you document relevant information.’
ADVERTORIAL BY LACORIUM
Dermal Therapy’s Scalp Relief range is clinically proven to relieve scalp itch and irritation in minutes. It is steroid- and tar-free and targets multiple common causes of itchy scalp.
Dermal Therapy Scalp Relief Serum is a leave-on product clinically proven to have similar effects to 0.1% Mometasone Furoate in reducing redness, itch and swelling within minutes. Formulated with colloidal oatmeal to soothe the scalp, Canadian Willowherb to calm irritation and menthol for its cooling effect.
Clinical study results:
The results are from a study conducted on 20 subjects by Dermatest®GmbH in Germany, an independent testing facility as commissioned and funded by Lacorium Health International Pty Ltd.
Working in conjunction with the Scalp Relief Serum, Dermal Therapy Scalp Relief Shampoo & Conditioner is a soap and SLS-free cleanser containing piroctone olamine for dandruff protection, 2% colloidal oatmeal and 2% urea to reduce flaking.
Both products are suitable for daily and long-term use.
Find out more here.
